Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $0.12.

  • SBC Medical Group Holdings' EPS (Basic) rose 30000.0% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.41, marking a year-over-year decrease of 2931.03%. This contributed to the annual value of $0.33 for FY2024, which is 2042.34% down from last year.
  • Per SBC Medical Group Holdings' latest filing, its EPS (Basic) stood at $0.12 for Q3 2025, which was up 30000.0% from $0.02 recorded in Q2 2025.
  • In the past 5 years, SBC Medical Group Holdings' EPS (Basic) ranged from a high of $0.21 in Q1 2025 and a low of -$0.06 during Q4 2024
  • Its 3-year average for EPS (Basic) is $0.09, with a median of $0.09 in 2023.
  • Over the last 5 years, SBC Medical Group Holdings' EPS (Basic) had its largest YoY gain of 77626.95% in 2024, and its largest YoY loss of 13945.25% in 2024.
  • SBC Medical Group Holdings' EPS (Basic) (Quarter) stood at $0.15 in 2023, then plummeted by 139.45% to -$0.06 in 2024, then soared by 302.78% to $0.12 in 2025.
  • Its EPS (Basic) stands at $0.12 for Q3 2025, versus $0.02 for Q2 2025 and $0.21 for Q1 2025.